RAG1 and cancer: To rule out that lymphopenia in RAG1−/− drives the observed CD40L-dependent cancer cell rejection by CD8+ T cells, we investigated the rejection of TAg+ cancer cells by CD40L+CD8+ T cells in a nonlymphopenic model.